These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28749241)

  • 1. Considerations for ADHD in the child with epilepsy and the child with migraine.
    Downs J; Giust J; Dunn DW
    Expert Rev Neurother; 2017 Sep; 17(9):861-869. PubMed ID: 28749241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
    Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS
    Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sleep organization in patients with attention deficit hyperactivity disorder (ADHD) and ADHD as a comorbidity of epilepsy.
    Kalil Neto F; Nunes ML
    Sleep Med; 2017 May; 33():91-96. PubMed ID: 28449914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate improves the quality of life of children and adolescents with ADHD and difficult-to-treat epilepsies.
    Radziuk AL; Kieling RR; Santos K; Rotert R; Bastos F; Palmini AL
    Epilepsy Behav; 2015 May; 46():215-20. PubMed ID: 25940104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key issues in addressing the comorbidity of attention deficit hyperactivity disorder and pediatric epilepsy.
    Salpekar JA; Mishra G
    Epilepsy Behav; 2014 Aug; 37():310-5. PubMed ID: 24835083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attention deficit hyperactivity disorder and epilepsy in childhood].
    Idiazábal-Alecha MA; Kosno M
    Rev Neurol; 2012 Feb; 54 Suppl 1():S89-93. PubMed ID: 22374777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
    Eiland LS; Bell EA; Erramouspe J
    Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of methylphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities.
    Gucuyener K; Erdemoglu AK; Senol S; Serdaroglu A; Soysal S; Kockar AI
    J Child Neurol; 2003 Feb; 18(2):109-12. PubMed ID: 12693777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy in a large cohort of children diagnosed with attention deficit/hyperactivity disorders (ADHD).
    Socanski D; Aurlien D; Herigstad A; Thomsen PH; Larsen TK
    Seizure; 2013 Oct; 22(8):651-5. PubMed ID: 23711613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing therapy of seizures in children and adolescents with ADHD.
    Aldenkamp AP; Arzimanoglou A; Reijs R; Van Mil S
    Neurology; 2006 Dec; 67(12 Suppl 4):S49-51. PubMed ID: 17190923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.
    Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Majnemer A
    Res Dev Disabil; 2012; 33(6):2080-7. PubMed ID: 22796639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity of migraine with ADHD.
    Fasmer OB; Riise T; Lund A; Dilsaver SC; Hundal O; Oedegaard KJ
    J Atten Disord; 2012 May; 16(4):339-45. PubMed ID: 21173430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.
    Clavenna A; Bonati M
    Expert Opin Drug Saf; 2017 Dec; 16(12):1335-1345. PubMed ID: 28984477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.
    Connor DF
    J Dev Behav Pediatr; 2002 Feb; 23(1 Suppl):S1-9. PubMed ID: 11875284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.
    Martens MA; Seyfer DL; Andridge RR; Foster JE; McClure KE; Coury DL
    Res Dev Disabil; 2013 May; 34(5):1700-9. PubMed ID: 23500164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.